Skip to main content
SpringerLink
Log in

C-erbB-2 immunoexpression in parathyroid tumors and hyperplasias

  • Clinical Research
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

C-erbB-2 is a proto-oncogene previously implicated in the pathogenesis and prognosis of several human tumors. The authors investigated c-erbB-2 immunoexpression in parathyroid tumors and hyperplasias, and correlated its presence with the diagnosis and severity of the parathyroid lesions. One hundred two parathyroid tissues (28 adenomas, 12 primary hyperplasias, 57 secondary hyperplasias, and 5 carcinomatous tissues) were studied. Membrane c-erbB-2 (either in the cell membrane or on the border of pseudocysts) was absent in normal glands, and detected in 50% of the adenomas, 25% of the primary hyperplasias, 100% of the carcinomas, and 12 and 53% of the secondarily diffuse and nodular hyperplasias, respectively. C-erbB-2 expression was significantly lower in diffuse hyperplasias than in other parathyroid lesions (P<0.05). Cytoplasmic c-erbB-2 expression (restricted to oxyphil cells) was found in 50% of the normal tissues and in variable frequency in parathyroid lesions. Mean gland mass and intact parathyroid hormone levels were not significantly different according to c-erbB-2 immunodetection. Mean serum ionized calcium was higher in c-erbB-2-positive adenomas than in negative ones (P=0.006). In conclusion, c-erbB-2 protein is frequently detected in hyperproliferative conditions of the parathyroid, such as neoplasms and hyperplasias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DeLellis RA. Atlas of Tumor Pathology—Tumors of the Parathyroid Gland, 3rd ser. Washington, DC: Armed Forces Institute of Pathology, 1991.

    Google Scholar 

  2. Grimelius L, Bondenson L. Histological diagnosis of parathyroid diseases. Pathol Res Pract 191:353–365, 1995.

    PubMed  CAS  Google Scholar 

  3. Hsi ED, Zukerberg LR, Yang WI, Arnold A. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 81:1736–1739, 1996.

    Article  PubMed  CAS  Google Scholar 

  4. Cryns VL, Rubio MP, Thor A, Louis DN, Arnold A. P53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78:1320–1324, 1994.

    Article  PubMed  CAS  Google Scholar 

  5. Subramaniam P, Wilkinson S, Shepherd JJ. P53 tumor suppressor gene expression in hyperparathyroidism. Aust NZ J Surg 66:302–304, 1996.

    CAS  Google Scholar 

  6. Hakim JP, Levine MA. Absence of p53 point mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 78:103–106, 1994.

    Article  PubMed  CAS  Google Scholar 

  7. Cryns VL, Thor A, Xu HJ, Hu SX, Wierman ME, Vickeryal JR. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 330:757–761, 1994.

    Article  PubMed  CAS  Google Scholar 

  8. Subramanian P, Wilkinson S, Shepherd JJ. Inactivation of retinoblastoma gene in malignant parathyroid growths:, a candidate genetic trigger? Aust NZ J Surg 65:714–716, 1995.

    Google Scholar 

  9. Vargas MP, Vargas HI, Kleiner DE, Merino MJ. The role of prognostic markers (MIB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol 10:12–17, 1997.

    PubMed  CAS  Google Scholar 

  10. Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U. The neu gene: an erb B-homologous gene distinct from and unlinked to the gene coding the EGF receptor. Science 229:976–978, 1985.

    Article  PubMed  CAS  Google Scholar 

  11. Coussens L, Yang-Feng TL, Liao YC, Chene, Gray A, McGrath J., et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–85; 1985.

    Article  PubMed  CAS  Google Scholar 

  12. McCann A, Dervan BA, Johnston BA, Gullick WJ, Carney DN. C-erbB-2 oncogene expression in primary human tumors. Cancer 65:88–92, 1990.

    Article  PubMed  CAS  Google Scholar 

  13. Knyazev PG, Imyanitov EN, C:hernitca OI, Nikiforova IF, Hanson KP. Amplification oferbB-2 (HER-2/NEW) oncogene in different neoplasms of patients from USSR. Oncology 49:1162–165, 1992.

    Article  Google Scholar 

  14. Van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dacesio O, et al. Neuprotein overexpression in breast cancer: association with comedo-type ductal carcinoma in-situ and limited prognostic value in stage II breast cancer. N Engl J Med 319:1239–1245, 1988.

    Article  PubMed  Google Scholar 

  15. Tetu B, Brisson J. Prognostic significance of HER-2/neu oncoprotein expression in nodepositive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy. Cancer 73:2359–2365, 1994.

    Article  PubMed  CAS  Google Scholar 

  16. Keshgegian AA, Cnaan A.erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody. Am J Clin Pathol 108:456–463, 1997.

    PubMed  CAS  Google Scholar 

  17. Ross JS, Nazeer T, Church K, Amato C, Figge H, Rifkin MD, et al. Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis. Cancer 72:3020–3028, 1993.

    Article  PubMed  CAS  Google Scholar 

  18. Sato K, Moriyama M, Mori S, Saito M, Watanuki T, Terada K, et al. An immunohistologic evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer 70:2493–2498, 1992.

    Article  PubMed  CAS  Google Scholar 

  19. D’Emilia J, Bulovas K, Dércole K, Wolf B, Steele G, Summerhayes IC. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene 4:1233–1239, 1989.

    PubMed  CAS  Google Scholar 

  20. Aasland R, Lillehaug JR, Male R, Jøsendal O, Varhaug JE, Kleppe K. Expression of oncogenes in thyroid tumours: co-expression of c-erbB2/neu and c-erbB. Br J Cancer 57:358–363, 1988.

    PubMed  CAS  Google Scholar 

  21. Haugen DR, Akslen LA, Varhaug JE, Lillehaug JR. Expression of c-erbB-2 protein in papillary thyroid carcinomas. Br J Cancer 65:832–837, 1992.

    PubMed  CAS  Google Scholar 

  22. Auguste L-J, Masood S, Westerband A, Belluco C, Valderamma E, Attie J. Oncogene expression in follicular neoplasms of the thyroid. Am J Surg 164:592–594, 1992.

    Article  PubMed  CAS  Google Scholar 

  23. Haugen DRF, Akslen LA, Varhaug JE, Lillehaug JR. Demonstration of a TGF-α-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas. Int J Cancer 55:37–43, 1993.

    Article  PubMed  CAS  Google Scholar 

  24. Akslen LA, Varhaug JE. Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival. Cancer 76:1643–1654, 1995.

    Article  PubMed  CAS  Google Scholar 

  25. Haugen DRF, Akslen LA, Varhaug JE, Lillehaug JR. Expression of c-erbB-3 and c-erbB-4 proteins in papillary, thyroid carcinomas. Cancer Res 56:1184–1188, 1996.

    PubMed  CAS  Google Scholar 

  26. Roncalli M, Springall DR, Varndell IM, Gaitonde VV, Hamid Q, Ibrahim NB, et al. Oncoprotein immunoreactivity in human endocrine tumors. J Pathol 163:117–127, 1991.

    Article  PubMed  CAS  Google Scholar 

  27. Castilla-Guerra L, Moreno AM, Fernández-Moreno MC, Utrilla JC, Fernánddez E, Galera-Davison H. Expression and prognostic value of c-erbB-2 oncogene product in human phaeochromocytomas. Histopathology 31:144–149, 1997.

    Article  PubMed  CAS  Google Scholar 

  28. Evers BM, Rády PL, Tyring SK, Sanchez RL, Rajaraman S, Townsend CM, Jr, et al. Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery 112:211–218, 1992.

    PubMed  CAS  Google Scholar 

  29. Falchetti A, Bale CAE, Amorosi A, Bordi C, Cicchi P, Bandini S. Progression of uremic hyperparathyroidism involves allelic loss of chromosome 11. J Clin Endocrinol Metab 76:139–144, 1993.

    Article  PubMed  CAS  Google Scholar 

  30. Vieira JG, Nishida SK, Kasamatsu TS, Amarante EC, Kunii IS. Development and clinical application of an immunofluorometric assay for intact parathyroid hormone. Brazilian J Med Biol Res 27:2379–82, 1994.

    CAS  Google Scholar 

  31. Hsu SM, Raine L, Fanger H. Use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29:577–580, 1981.

    PubMed  CAS  Google Scholar 

  32. De Potter CR, Quatacker J, Maerttens G, Van Daele S, Pauwels C, Verhofstede C, et al. The subcellular localization of theneu protein in human normal and neoplastic cells. Int J Cancer 44:969–974, 1989.

    Article  PubMed  Google Scholar 

  33. Kay EW, Walsh CJB, Cassidy M, Curran B, Leader M. C-erbB-2 immunostaining: problems with interpretation. J Clin Pathol 47:816–822, 1994.

    Article  PubMed  CAS  Google Scholar 

  34. Tannapfel A, Kuhn R, Kessler H, Wittekin C. Expression of c-erbB-2 oncogene product in different tumours and its standardised evaluation. Anal Cell Pathol 10:149–160, 1996.

    PubMed  CAS  Google Scholar 

  35. Kihana T, Tsuda H, Teshima S, Nomoto K, Tsugane S, Sonoda T, et al Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix. Cancer 73:148–153, 1994.

    Article  PubMed  CAS  Google Scholar 

  36. Falck VG, Gullick WJ. C-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol 159:107–111, 1989.

    Article  PubMed  CAS  Google Scholar 

  37. Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, et al. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res 49:4968–4971, 1989.

    PubMed  CAS  Google Scholar 

  38. Berchuck A, Rodrigues G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL, et al. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol 164:15–21, 1991.

    PubMed  CAS  Google Scholar 

  39. Nosé-Alberti V, Mesquita MIS, Martin LC, Kayath MJ. Adrenocorticotropin-producing pituitary carcinoma with expression of c-erbB-2 and high PCNA index: a comparative study with pituitary adenomas and normal pituitary tissues. Endocr Pathol 9:1–9, 1998.

    Google Scholar 

  40. Corbett IP, Henry JA, Angus B, Watchorn CJ, Wilkinson L, Hennessy C, et al. NCL-BII, a new monoclonal antibody recognising the internal domain of the c-erbB-2 oncongene protein effective for use on formalin-fixed paraffin embedded tissue. J Pathol 161:15–25, 1990.

    Article  PubMed  CAS  Google Scholar 

  41. Keatings L, Sinclair J, Wright C, Corbett IP, Watchorn C, Hennessy C, et al. C-erbB-2 oncoprotein expression in mammary and extramammary Paget’s disease: an immunohistochemical study. Histopathology 171:243–247, 1990.

    Article  Google Scholar 

  42. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644–1646, 1986.

    Article  PubMed  CAS  Google Scholar 

  43. Kay EW, Mulcahy H, Walsh CB, Leader M, O’Donoghue D. Cytoplasmic c-erbB-2 protein expression correlates with survival in Dukes’ B colorectal carcinoma. Histopathology 25:455–461, 1994.

    Article  PubMed  CAS  Google Scholar 

  44. De Potter CR, Van Daele S, Van de Vijver MJ, Pauwels C, Maertens G, De Boeuer J, et al. The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues. Histopathology 15:351–362, 1989.

    Article  PubMed  Google Scholar 

  45. Natali PG, Nicotra MR, Bigotti A, Venturo I, Slamon DJ, Fendly BM, et al. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int J Cancer 45:457–461, 1990.

    Article  PubMed  CAS  Google Scholar 

  46. Gogusev J, Duchambon P, Stoermann-Chopard C, Giovannini M, Sarfati E, Drueke TB. De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 11:2155–2162, 1996.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Escola Paulista de Medicina, Federal University of São Paulo, Caixa Postal 20266, 04034-970, São Paulo, SP, Brazil

    Marcia J. Kayath, Luciana C. Martin & José Gilberto H. Vieira

  2. Department of Pathology Escola Paulista de Medicina, Federal University of São Paulo, Caixa Postal 20266, 04034-970, São Paulo, SP, Brazil

    Vânia Nosé

Authors
  1. Marcia J. Kayath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luciana C. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José Gilberto H. Vieira
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vânia Nosé
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcia J. Kayath.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kayath, M.J., Martin, L.C., Vieira, J.G.H. et al. C-erbB-2 immunoexpression in parathyroid tumors and hyperplasias. Endocr Pathol 10, 47–54 (1999). https://doi.org/10.1007/BF02738815

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02738815

Key Words

Search

Navigation